Stock Events

Stock Events

THX Pharma 

€3.59
31
-€0.29-7.36% 06:04 Today

Statistics

Day High
3.59
Day Low
3.59
52W High
4.49
52W Low
1.71
Volume
0
Avg. Volume
128
Mkt Cap
49.46M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 3VG.MU. It's not an investment recommendation.
Engie
8
ENGI.PA
TotalEnergies
7
TTE.PA
Axa
7
CS.PA
Credit Agricole.
7
ACA.PA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap32.63B
Biogen focuses on neurology and has a strong pipeline in neurological disorders, directly competing with Theranexus's focus on the central nervous system.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly has a significant presence in the neurology space, including treatments for Alzheimer's, which overlaps with Theranexus's therapeutic areas.
Novartis
NVS
Mkt Cap304.1B
Novartis has a broad portfolio in neuroscience, competing in the development of treatments for neurological conditions.
Pfizer
PFE
Mkt Cap162.16B
Pfizer has a history of developing drugs for neurological diseases, competing with Theranexus in the neurology market.
Merck
MRK
Mkt Cap370.89B
Merck is involved in neurology and has been focusing on treatments for conditions like Alzheimer's, directly competing with Theranexus's focus areas.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie has a growing interest in neuroscience, including R&D in neurodegenerative diseases, making it a competitor to Theranexus.
AMGEN
AMGN
Mkt Cap236.38B
Amgen has initiatives in neuroscience, particularly in migraine treatments, which could overlap with Theranexus's therapeutic targets.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.37B
Teva Pharmaceutical is a key player in the generic and specialty medicine space, including neurology, competing with Theranexus in terms of therapeutic solutions.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca has a diversified portfolio that includes neuroscience, competing with Theranexus in research and development of neurological treatments.

About

Theranexus, a biopharmaceutical enterprise, specializes in the creation of potential medications for ailments affecting the central nervous system. Their primary investigational compound, THN102, is presently undergoing Phase II clinical evaluation for conditions related to sleep and wake cycles. Furthermore, they are developing THN201 to target neurocognitive challenges associated with Alzheimer's disease, and THN101 for the management of neuropathic discomfort. This company commenced operations in 2013 and is situated in Lyon, France.
Show more...
CEO
Mathieu Charvériat
Employees
12
Country
France
ISIN
FR0013286259
WKN
000A2H6LX

Listings

STU
DE
3VG.STU
PA
FR
ALTHX.PA
MU
DE
3VG.MU
F
DE
3VG.F

0 Comments

Share your thoughts

FAQ

What is THX Pharma stock price today?▼
The current price of 3VG.MU is €3.59 EUR — it has decreased by -7.36% in the past 24 hours. Watch THX Pharma stock price performance more closely on the chart.
What is THX Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange THX Pharma stocks are traded under the ticker 3VG.MU.
Is THX Pharma stock price growing?▼
3VG.MU stock has fallen by -14.54% compared to the previous week, the month change is a -20.16% fall, over the last year THX Pharma has showed a +34.12% increase.
What is THX Pharma market cap?▼
Today THX Pharma has the market capitalization of 49.46M
What is THX Pharma revenue for the last year?▼
THX Pharma revenue for the last year amounts to 0 EUR.
What is THX Pharma net income for the last year?▼
3VG.MU net income for the last year is -3M EUR.
How many employees does THX Pharma have?▼
As of September 10, 2026, the company has 12 employees.
In which sector is THX Pharma located?▼
THX Pharma operates in the Health & Wellness sector.
When did THX Pharma complete a stock split?▼
THX Pharma has not had any recent stock splits.
Where is THX Pharma headquartered?▼
THX Pharma is headquartered in Lyon, France.